Market
Which region will Aqemia target next for global expansion by end of 2025?
2
Resolution / Starting Odds
Europe • 25%
North America • 25%
Asia • 25%
Other • 25%
Official announcements from Aqemia or credible news sources
Story
Aqemia Secures $38 Million Funding, Hits $100 Million Milestone for Drug Discovery Expansion in London
Dec 10, 2024, 11:17 AM
Aqemia, a Paris-based start-up focused on drug discovery, has successfully raised $38 million in a funding round led by Cathay Innovation. This new funding adds to the company's previous €30 million raised in January 2024. The capital will enable Aqemia to advance its clinical trials and expand its operations globally, beginning with a new office in London, UK. The company utilizes a unique approach that combines theoretical physics and generative AI to enhance drug discovery processes, marking a significant step in the integration of advanced technologies in pharmaceuticals.
View original story
Similar markets
Europe • 25%
North America • 25%
Latin America • 25%
Africa • 25%
Asia • 25%
North America • 25%
Australia • 25%
Africa • 25%
Other • 25%
Asia • 25%
South America • 25%
Europe • 25%
Other • 25%
China • 25%
United States • 25%
Europe • 25%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
Asia • 25%
Europe • 25%
Other • 25%
South America • 25%
Africa • 25%
Middle East • 25%
Asia-Pacific • 25%
South America • 25%
European Union • 20%
North Korea • 20%
Russia • 20%
China • 20%
United Kingdom • 20%
Europe • 25%
Asia-Pacific • 25%
Other • 25%
North America • 25%
China • 25%
India • 25%
Japan • 25%
Other • 25%
Other • 25%
Africa • 25%
Southeast Asia • 25%
South America • 25%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%